Lanari M - Search Results

1

Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants.

Baraldi E, Lanari M, Manzoni P, Rossi GA, Vandini S, Rimini A, Romagnoli C, Colonna P, Biondi A, Biban P, Chiamenti G, Bernardini R, Picca M, Cappa M, Magazzù G, Catassi C, Urbino AF, Memo L, Donzelli G, Minetti C, Paravati F, Di Mauro G, Festini F, Esposito S, Corsello G. Baraldi E, et al. Among authors: lanari m. Ital J Pediatr. 2014 Oct 24;40:65. doi: 10.1186/1824-7288-40-65. Ital J Pediatr. 2014. PMID: 25344148 Free PMC article.

2

High risk of nosocomial-acquired RSV infection in children with congenital heart disease.

Lanari M, Rossi GA, Merolla R, di Luzio Paparatti U. Lanari M, et al. J Pediatr. 2004 Jul;145(1):140; author reply 140-1. doi: 10.1016/j.jpeds.2004.03.029. J Pediatr. 2004. PMID: 15264354 No abstract available.

3

Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics.

Rossi GA, Medici MC, Arcangeletti MC, Lanari M, Merolla R, Paparatti UD, Silvestri M, Pistorio A, Chezzi C; Osservatorio RSV Study Group. Rossi GA, et al. Among authors: lanari m. Eur J Pediatr. 2007 Dec;166(12):1267-72. doi: 10.1007/s00431-007-0418-y. Epub 2007 Feb 17. Eur J Pediatr. 2007. PMID: 17308898 Free PMC article.

4

Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes.

Resch B, Manzoni P, Lanari M. Resch B, et al. Among authors: lanari m. Paediatr Respir Rev. 2009 Sep;10(3):148-53. doi: 10.1016/j.prrv.2009.06.003. Epub 2009 Jul 19. Paediatr Respir Rev. 2009. PMID: 19651386 Review.

5

Respiratory syncytial virus risk factors in late preterm infants.

Lanari M, Silvestri M, Rossi GA. Lanari M, et al. J Matern Fetal Neonatal Med. 2009;22 Suppl 3:102-7. doi: 10.1080/14767050903194438. J Matern Fetal Neonatal Med. 2009. PMID: 19925369

6

Hospitalization for lower respiratory tract disease in preterm infants: effects of prophylaxis with palivizumab.

Faldella G, Alessandroni R, Aquilano G, Vandini S, Lanari M, Silvestri M, Pistorio A, Rossi GA. Faldella G, et al. Among authors: lanari m. J Chemother. 2010 Feb;22(1):30-5. doi: 10.1179/joc.2010.22.1.30. J Chemother. 2010. PMID: 20227990

7

Should the American Academy of Pediatrics respiratory syncytial virus guidelines be modified?

Rossi GA, Silvestri M, Lanari M. Rossi GA, et al. Among authors: lanari m. Pediatrics. 2010 Apr;125(4):e1021; author reply e1022. doi: 10.1542/peds.2010-0607a. Pediatrics. 2010. PMID: 20360416 No abstract available.

8

Palivizumab prophylaxis in 'late preterm' newborns.

Lanari M, Silvestri M, Rossi GA. Lanari M, et al. J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:53-5. doi: 10.3109/14767058.2010.506757. J Matern Fetal Neonatal Med. 2010. PMID: 20695756 Review.

9

Clinical and pharmacological aspects of immunoprophylaxis for respiratory syncytial virus infection in high-risk infants.

Lanari M, Silvestri M, Rossi GA. Lanari M, et al. Curr Drug Metab. 2013 Feb;14(2):216-25. Curr Drug Metab. 2013. PMID: 22935064 Review.

10

Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants.

Vandini S, Corvaglia L, Alessandroni R, Aquilano G, Marsico C, Spinelli M, Lanari M, Faldella G. Vandini S, et al. Among authors: lanari m. Ital J Pediatr. 2013 Jan 11;39(1):1. doi: 10.1186/1824-7288-39-1. Ital J Pediatr. 2013. PMID: 23311474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page